Evidence map›Paper›PMID 20307795›Full record

ArticleJournal of substance abuse treatment2010

A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.

Paul M Roman, Amanda J Abraham, Tanja C Rothrauff, Hannah K Knudsen

Registry-linked trialAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03098407 (A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.), which is not on this map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03098407 nacompletednot on this mapstarted 2017, after this paper: background citation

A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.

TypeinterventionalSponsorUniversity of PittsburghRan2017 to 2020Enrolled55ConditionsOpioid-Related Disorders, PregnancyArmsBuprenorphine, Methadone
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. The dissemination and implementation of contingency management for substance use disorders: A systematic review.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2020
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Psychotherapies in opioid use disorder: toward a step-care model.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Technology transfer for the implementation of a clinical trials network on drug abuse and mental health treatment in Mexico.Revista panamericana de salud publica = Pan American journal of public health · 2015
    Article
  15. Article
  16. Dissemination activities: a critical new role for substance abuse treatment organizations.The journal of behavioral health services & research · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Improving treatment for opioid dependence: a perspective from the Ohio Valley node of the NIDA Clinical Trials Network.Progress in community health partnerships : research, education, and action · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paul M RomanInstitute for Behavioral Research, University of Georgia, Athens, GA 30602-2401, USA.
Amanda J Abraham
Tanja C Rothrauff
Hannah K Knudsen

Funding

CTN Membership and Adoption of Innovative Tx PracticesR01DA014482 · NIDA · UNIVERSITY OF GEORGIA (UGA) · PI ROMAN, PAUL M · 2001 to 2011
$8.0M
Diffusion, Adoption, and Implementation of Pharmacotherapies in Alcohol TxF32AA016872 · NIAAA · UNIVERSITY OF GEORGIA · PI ABRAHAM, AMANDA J · 2007 to 2009
$144k
NIAAA NIH HHS F32 AA016872NIDA NIH HHS R01 DA014482NIDA NIH HHS R01DA14482
6 · The paper itself

Abstract

The National Institute on Drug Abuse established the National Drug Abuse Treatment Clinical Trials Network (CTN) to conduct trials of promising substance abuse treatment interventions in diverse clinical settings and to disseminate results of these trials. This article focuses on three dimensions of CTN's organizational functioning. First, a longitudinal dataset is used to examine CTN's formation as a network of interorganizational interaction among treatment practitioners and researchers. Data indicate strong relationships of interaction and trust, but a decline in problem-centered interorganizational interaction over time. Second, adoption of buprenorphine and motivational incentives among CTN's affiliated community treatment programs (CTPs) is examined over three waves of data. Although adoption is found to increase with CTPs' CTN participation, there is only modest evidence of widespread penetration and implementation. Third, CTPs' pursuit of the CTN's dissemination goals are examined, indicating that such organizational outreach activities are underway and likely to increase innovation diffusion in the future.

Indexed as

Diffusion of InnovationBuprenorphineClinical Trials as TopicCommunity Health ServicesEvidence-Based MedicineHumansInformation DisseminationMotivationNarcotic AntagonistsNational Institute on Drug Abuse (U.S.)Substance Abuse Treatment CentersSubstance-Related DisordersTime FactorsUnited StatesBuprenorphineNarcotic Antagonists

Identifiers

PMID20307795
PMCPMC2844868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.